Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma

In Vitro Cellular and Developmental Biology - Animal

Volumn 44, Issue 3-4, 2008, Pages 87-95

  Gillette, Jennifer M ^a   Gibbs, C Parker ^b   Nielsen Preiss, Sheila M ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

Author keywords

Cell line; Mineralization; Osteoblast; Osteosarcoma; Tumorigenicity

Indexed keywords

AGGRECAN; ALKALINE PHOSPHATASE; CISPLATIN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; DOXORUBICIN; LINK PROTEIN; METHOTREXATE; OSTEOCALCIN; OSTEONECTIN; PROTEIN P53; SIALOPROTEIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CANCER INVASION; CASE REPORT; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL STRAIN; CHICK EMBRYO; CHROMOSOME G BAND; DRUG MEGADOSE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; MINERALIZATION; MOLECULAR MECHANICS; OSTEOSARCOMA; OSTEOSARCOMA CELL; OSTEOSARCOMA CELL OS 99 1; SCHOOL CHILD; TREATMENT OUTCOME; ANIMAL; BONE MINERALIZATION; BONE TUMOR; GENE EXPRESSION PROFILING; KARYOTYPING; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHICK EMBRYO; GENE EXPRESSION PROFILING; HUMANS; KARYOTYPING; OSTEOSARCOMA;

EID: 50149100579     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-007-9075-8     Document Type: Article

References (29)

1. M. Ballester A. Castello 2004 Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals Biotechniques 37 610 613
2. D.A. Belchis C.D. Gocke 2000 Alterations in the RB, p16, and cyclin D1 cell cycle control pathway in osteosarcomas Pediatr. Pathol. Mol. Med. 19 377 389
3. J. A. Biegel R.B. Womer 1989 Complex karyotypes in a series of pediatric osteosarcomas Cancer Genet. Cytogenet. 38 89 100
4. G. Bilbe G. Roberts 1996 PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines Bone 19 437 445
5. A.K. Boehm J.R. Neff 2000 Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature Pediatr. Pathol. Mol. Med. 19 359 376
6. J. Bridge M. Nelson 1997 Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature Cancer Genet. Cytogenet. 95 74 87
7. L. Chauveinc V. Mosseri 2001 Osteosarcoma following retinoblastoma: age at onset and latency period Ophthalmic Genet. 22 77 88
8. L.W. Fisher J.T. Stubbs 1995 Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins Acta Orthop. Scand. Suppl. 266 62 65
9. J.A. Fletcher M.C. Gebhardt 1994 Cytogenetic aberrations in osteosarcomas: nonrandom deletions, rings, and double-minute chromosomes Cancer Genet Cytogenet 77 81 88
10. J.M. Gillette S.M. Nielsen-Preiss 2004 The role of annexin 2 in osteoblastic mineralization J. Cell Sci. 117 441 449
11. T. Jacks L. Remington 1994 Tumor spectrum analysis in p53-mutant mice Curr. Biol. 4 1 7
12. R.P. Jensh R.L. Brent 1966 Rapid schedules for KOH clearing and Alizarin red S staining of fetal rat bone Stain. Technol. 41 179 183
13. S. Kim J. Choi 2004 Imaging findings of extrapulmonary metastases of osteosarcoma Clin Imaging 28 4 291 230
14. F.D. Kitchin R.M. Ellsworth 1974 Pleiotropic effects of the gene for retinoblastoma J. Med. Genet. 11 244 246
15. Lian J.; Stein G et al. Bone formation: osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process. In: FavusM. (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Lippincott Williams & Wilkins, Philadelphia, pp 14-29; 1999.
16. G. Lim J. Karaskova 2004 Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangement associated with gene amplification in the osteosarcoma cell line MG-63 Cancer Genet. Cytogenet. 153 158 164
17. F. Lui L. Malaval 1997 The mature osteoblast phenotype is characterized by extensive plasticity Exp. Cell. Res. 232 97 105
18. N.M. Marina C.B. Pratt 1992 Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis Cancer 70 2722 2727
19. H. Masuda C. Miller 1987 Rearrangement of the p53 gene in human osteogenic sarcomas." Proc. Natl. Acad. Sci. USA 84 7716 7719
20. F. Mertens N. Mandahl 1993 Cytogenetic findings in 33 osteosarcomas. Int. J. Cancer 55 44 50
21. P.A. Meyers G. Heller 1992 Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience J. Clin. Oncol. 10 5 15
22. P.A. Meyers G. Heller 1993 Osteogenic sarcoma with clinically detectable metastasis at initial presentation J. Clin. Oncol. 11 3 449 453
23. S. Mousses L. McAuley 1996 Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas Mod. Pathol. 9 1 6
24. S.M. Nielsen-Preiss J.P. Quigley 1993 Detection and characterization of low abundance cellular proteins that specifically increase upon loss of the metastatic phenotype J. Cell Biochem. 51 219 235
25. S.M. Nielsen-Preiss J.P. Quigley 1999 Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines Clin. Exp. Mets. 17 489 496
26. L. Ossowski E. Reich 1980 Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters Cancer Res. 40 2310 2315
27. N. Rochet J. Dobousset 1999 Establishment, characterization and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72) Int. J. Cancer 82 282 285
28. A. Sandberg J. Bridge 2003 Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors Cancer Genet. Cytogenet. 145 1 30
29. T. Yamaguchi J. Toguchida 1992 Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p and 18q Cancer Res. 52 2419 2423